Clinical Trial
doi: 10.1016/0016-5085(92)90867-x.
Maintenance of remission in Crohn's disease: is 5'-aminosalicylic acid the answer?
- PMID: 1353043
- DOI: 10.1016/0016-5085(92)90867-x
Item in Clipboard
Clinical Trial
Maintenance of remission in Crohn's disease: is 5'-aminosalicylic acid the answer?
Gastroenterology.
1992 Aug.
No abstract available
Comment on
-
Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease.Gastroenterology. 1992 Aug;103(2):363-8. doi: 10.1016/0016-5085(92)90822-g. Gastroenterology. 1992. PMID: 1634054 Clinical Trial.
Similar articles
-
The role of mesalazine in Crohn's disease.Scand J Gastroenterol Suppl. 1990;172:56-9. doi: 10.3109/00365529009091912. Scand J Gastroenterol Suppl. 1990. PMID: 1972296 Review.
-
[Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].Dtsch Med Wochenschr. 1986 May 2;111(18):721-2. Dtsch Med Wochenschr. 1986. PMID: 2870908 German. No abstract available.
-
Is maintenance therapy effective in Crohn's disease?Lancet. 1994 Oct 1;344(8927):900-1. doi: 10.1016/s0140-6736(94)92261-6. Lancet. 1994. PMID: 7934340 No abstract available.
-
Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.Am J Gastroenterol. 1994 Dec;89(12):2116-24. Am J Gastroenterol. 1994. PMID: 7977225
-
Maintenance of symptomatic remission in patients with Crohn's disease.Mayo Clin Proc. 1993 Dec;68(12):1183-90. doi: 10.1016/s0025-6196(12)60070-6. Mayo Clin Proc. 1993. PMID: 7902474 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
